Country:
Years:
Category:

Algal Bio Co., Ltd.

Algal Bio Co., Ltd., a biotech startup, was established in March 2018 based upon 20 years of research results at the University of Tokyo. We possess around 3000 algae strains.These algae strains produce naturally occurring functional substances such as carotenoids, long chain unsaturated fatty acids , protein and oils. In addition to the strains isolated from the environment, these algae strains include strains obtained by mutation breeding with heavy ion-beam irradiation. The need for biologically-derived functional substances is increasing globally due to consumer health and natural orientation, the avoidance of genetic modification, and various regulations on chemically synthesized substances. Our algae strain does not use genetic recombination technology, so it can meet a wide range of needs. We can provide functional substance, functional foods (health foods and supplements), cosmetics, functional beverages, natural additives, medicines and biofuels, etc.

Read More→

Hachi Tama Inc.

Our product is called “Toletta®” it is a smart IoT cat litter box that has different layers to separate urine and feces for easier and more convenient clean up. This system also ideal for detecting any abnormalities in your cat’s health that may not be directly noticeable, such as Chronic Kidney Disease. Chronic Kidney Disease is an incurable disease that affects 30% of the whole cat population, it is also tone of the leading causes in cat death. Early symptoms of this disease include an increased urine volume and decreased body weight, which toletta can measure simultaneously. We can also distinguish between various cats via our camera/face recognition technology, and all of your specific cat’s information will be available on our app, which makes our product more convenient for those who lead busy lives like those in the workforce or those who have limited energy to take care of their pet, such as the elderly. Our technology is very unique and innovative to the pet industry because we can help provide early detection, which leads to early treatment to one’s cat, which can prolong their lives so that everyone can live a happy cat life.

Read More→

FUTURUN TECHNOLOGIES

An uptick in the lifestyle, triggered by jet-speed urbanization and industrialization, at times reveal a few clefts. The change takes people afar from the root which can adversely impact the body. One such is hypertension or high blood pressure. If allowed to persist longer, then it has the potential to lead to much more demanding diseases such as heart failure, stroke, peripheral vascular disease, chronic kidney disease, and others. To counter the disease, anti-hypertensive drugs have been introduced by various drug manufacturers. These drugs are primarily chemicals that can lower high blood pressure or tension and curb chances of contracting myocardial infarction or stroke. Keeping an eye on our blood pressure level is very important for a healthy heart and organ function. If not properly monitored and maintained, high or low blood pressure levels can lead to an assortment of health risks.
With our Smart Intelligent Materials, that show non-radioactive alpha, beta and gamma rays, non-toxic, non-conductive, non-migrating and non-magnetic properties, it can stabilize blood pressure. Through its unique chemical interaction of the impregnated materials in the plaster, it emits a low-frequency vibration to the blood, thus improving its circulation.

Read More→

MOTORICA LLC

Motorica is a company with offices in Russia (HQ), China and India focusing on research and development in medicine and robotics. Since its establishment, the company has been developing artificial hand systems and rehabilitation with assistive technologies. Half of the team are R&D staff and medical specialists.
 Motorica challenges the outdated ideas about prosthetic care. The team taught prostheses to communicate with the user, go online, perform voice commands, pay for purchases. In 2018, Motorica launched the development of a rehabilitation platform based on virtual reality and a platform for collecting telemetry via gsm-module in prosthetic devices. Nowadays, people with disabilities become the primary users of the cyber technology market and turn weaknesses into strengths.

Read More→

UNIM

UNIM is a Russian medical IT company who develops solutions for oncology diagnostics. Company has created Digital Pathology© system – end-to-end solution for digitalization of the pathomorphological laboratory. UNIM has opened 100% digital pathology laboratory in Technopark Skolkovo in January 2018, where more than 3,500 patients get their diagnosis every month. More than 1000 highly specialized consultants use the Digital Pathology© system to meet remotely via the Internet same as they would at a multi-head microscope, and perform real-time case analysis. Digital Pathology© provides collective work on each case, attraction of narrow specialists from all over the world, transparency of the diagnostic process, opportunities for interdisciplinary communication and integration of neural networks in diagnostic process. The company combines all the competencies necessary to develop a competitive convenient product and its successful commercialization: management, developers, doctors, sales.

Read More→

AcroViz Inc.

AcroViz develops novel imaging biomarkers for brain health, in an effort to prolong human health span and aims to end dementia with state-ofart technologies. Comprising of members who were research fellows at eminent academia and experienced industrial professionals, our team are devoted to advance scientific research, its clinical significance and application, as well as commercialization of our technologies to achieve extended impact. Our first product: AcroViz Axonal Brain Age – Brain Health Report, is the first to the market, adopting diffusion Magnetic Resonance Imaging (MRI) and Machine Learning techniques to provide accurate and objective brain health assessment, which can serve as a Mild Cognitive Impairment (MCI) marker in predicting the risk and prognosis of dementia, such as Alzheimer’s Disease (AD). AcroViz aims to end dementia with advanced neuroimaging technologies, currently working with medical or health-care institutions, and pharma or medical device companies, on various clinical trials to validate the effectiveness of intervention on MCI patients.

Read More→

Diagnostring Laboratories India Private Limited

At present, India requires better and affordable health care products for aggressive diseases like cancer. Currently, millions of Indian patients do not have access to right health care products, as they are not available in India. Majority of the hospitals in India still depend on the Western technologies that are not accessible.
With the new Make-in-India initiative introduced by our current Prime Minister, Diagnostring Laboratories believed to be a first Indian company to innovate and develop cancer and genomics based health care and diagnostic products.

Read More→

PLIMES Inc

PLIMES Inc. is a university spin-off company launched to create a pathway to market for academic research innovations originating from the research achievements at the Artificial Intelligence Laboratory, Center for Cybernics Research and Center for Innovative Medicine and Engineering at the University of Tsukuba, Japan.
PLIMES Inc. is managed by the cofounders Kenji Suzuki, PhD(Eng.), Tomoya Shimokakimoto, PhD(Eng.) and MSc (Med. Sc.), Dushyantha Jayatilake, PhD(Eng.) who each have over 15 years of experience in developing healthcare/robotics technologies and Atsushi Nitasaka (CEO of ZINE), who has experience in launching successful startups and the know-how to reach out using modern media strategies. In addition, we have a comprehensive board of medical advisors to accurately shape the technology to match the need. We are social enablers and PLIMES Inc. focuses on the social problem-solving business by operating to dramatically enhance user experience and social interaction for people with special needs. We spent over 10 years in the academia developing these fundamental technologies that are finally ready to be transferred to the society.

Read More→